ERNA vs SPCE · P/E 0.0, rev $582.0K vs rev $7.0M
Eterna Therapeutics Inc (ERNA) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the ERNA and SPCE stock pages for the full models.
Not investment advice.